Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.

This early-stage trial tested a new injectable drug called CPX101 in 72 healthy volunteers and overweight or obese patients. The main goal was to check safety and how the body processes the drug, with a preliminary look at weight loss. The study is complete, but results are not y…

This study tested a new drug called CPX101 in 240 overweight or obese adults without diabetes. Participants received different doses of CPX101 or a placebo by injection for 24 weeks. The goal was to see if the drug helps with weight loss and to check its safety.